ONCOLOGY
ASCO 2021 Liver Cancer Update

ASCO 2021 Liver Cancer Update

The liver cancer trials presented at American Society of Clinical Oncology (ASCO) 2021 were mainly focused on first-line treatments, with a few trials in the neoadjuvant, adjuvant and second-line setting.
LATEST
detecting metastases with psma pet in prostate cancer

Detecting metastases with PSMA-PET in prostate cancer

Conventional imaging with computed tomography (CT), magnetic resonance imaging (MRI) and bone scans, are the current standard of care for imaging prostate cancer. Accurate imaging primarily relies on nodal metastases size for detection.
OTHER
The Role of Patient Blood Management for Inflammatory Bowel Disease-01

The Role of Patient Blood Management for Inflammatory Bowel Disease

Dr Michael Li, a consultant physician and head of Division of Gastroenterology at Tuen Mun Hospital presented a lecture about the implementation of patient blood management (PBM) and use of intravenous (IV) iron in patients with inflammatory bowel disease (IBD) on October 8, 2020.
CANCERINFORMER
腫瘤學新知 Cancer Informer 癌症資訊 癌症治療 癌症 腫瘤 確診患癌 究竟甚麼是癌 癌症怎樣醫
MediPaper Medical Communications Ltd
BREAKING
Dr Sridhar Siddharth - Clinical characteristics of patients with 2019-nCoV pneumonia WARS Wuhan Pneumonia coronavirus outbreak sars mers COVID-19 2019-nCoV WuhanOutbreak Pneumonia
MediPaper Medical Communications Ltd
irAE immune-related adverse events immune-mediated adverse events hepatitis pneumonitis rash diabetes_small
©invincible7 / 123RF Stock Photo
CONFERENCE HIGHLIGHTS
ESMO-2018-ESMO18-pembrolizumab-nivolumab-durvalumab-atezolizumab-avelumab-ipilimumab-tremelimumab-osimertinib-cabozantinib-lenvatinib-lorlatinib
©European Society for Medical Oncology
ECTRIMS2018 multiple sclerosis MS neurology
©ECTRIMS
ASCO 2018 ASCO18 pembrolizumab nivolumab durvalumab atezolizumab avelumab ipilimumab tremelimumab olaparib rucaparib niraparib PARP palbociclib ribociclib abemaciclib CDK46 osimertinib cabozantinib lenvatinib lorlatinib
©American Society for Clinical Oncology (ASCO)
aacr2018 american association for cancer research annual meeting 2018 AACR 2018 AACR annual meeting 2018
©American Association for Cancer Research
CSA2017-0-中华医学会第25-次全国麻醉学术年会-2017-郑州-25th-Annual-Meeting-of-the-Chinese-Society-of-Anaesthesiology
©Chinese Society for Anesthesiology
esmo 2016
© European Society for Medical Oncology

Therapeutic Areas

Or, sign up for our newsletter


Therapeutic Areas

ONCOLOGY ARTICLES
ASCO 2021 Liver Cancer Update

ASCO 2021 Liver Cancer Update

The liver cancer trials presented at American Society of Clinical Oncology (ASCO) 2021 were mainly focused on first-line treatments, with a few trials in the neoadjuvant, adjuvant and second-line setting.
cancer informer 腫瘤學新知 分享腫瘤領域最新進展 包含熱議話題、專題和實用工具 例如 NCCN ASCO 及 ESMO 消息更新
MediPaper Medical Communications Ltd
Dr Sridhar Siddharth - Clinical characteristics of patients with 2019-nCoV pneumonia WARS Wuhan Pneumonia coronavirus outbreak sars mers COVID-19 2019-nCoV WuhanOutbreak Pneumonia
MediPaper Medical Communications Ltd
irAE immune-related adverse events immune-mediated adverse events hepatitis pneumonitis rash diabetes_small
©invincible7 / 123RF Stock Photo
ONCOLOGY ARTICLES (Cont’d)
Capmatinib therapy for the treatment of MET-positive non-small cell lung cancer

Capmatinib therapy for the treatment of MET-positive non-small cell lung cancer

A number of tyrosine kinase inhibitors (TKIs) are now available for the treatment of various types of non-small cell lung cancers (NSCLC), including epidermal growth factor receptor (EGFR)-mutated and anaplastic lymphoma kinase (ALK)-rearranged NSCLC. However, amplification of the MET gene, which codes for the hepatocyte growth factor receptor (HGFR), has been found to be one of the most prominent mechanisms of secondary resistance to EGFR TKIs. Similarly, the MET exon 14 (METex14) mutation has also emerged as a potential tumour driver due to its role in cancer proliferation, and thus also a promising target for NSCLC.
ESMO-2018-ESMO18-pembrolizumab-nivolumab-durvalumab-atezolizumab-avelumab-ipilimumab-tremelimumab-osimertinib-cabozantinib-lenvatinib-lorlatinib
©European Society for Medical Oncology
ECTRIMS2018 multiple sclerosis MS neurology
©ECTRIMS
ASCO 2018 ASCO18 pembrolizumab nivolumab durvalumab atezolizumab avelumab ipilimumab tremelimumab olaparib rucaparib niraparib PARP palbociclib ribociclib abemaciclib CDK46 osimertinib cabozantinib lenvatinib lorlatinib
©American Society for Clinical Oncology (ASCO)
OTHER ARTICLES
data-for-safe-and-effective-use-of-evolocumab-in-paediatric-familial-hypercholesterolaemia

Data for safe and effective use of evolocumab in paediatric familial hypercholesterolaemia

While SARS-CoV2 has been previously reported to exist in lung tissue in a 78-year-old patient who died of unexpected cardiac arrest when ready for discharge after COVID-19 hospitalisation, recently the first evidence of SARS-CoV2 infection in heart muscle cells has been reported in a case from Brazil and which is supported by evidence from other reports.
aacr2018 american association for cancer research annual meeting 2018 AACR 2018 AACR annual meeting 2018
©American Association for Cancer Research
CSA2017-0-中华医学会第25-次全国麻醉学术年会-2017-郑州-25th-Annual-Meeting-of-the-Chinese-Society-of-Anaesthesiology
©Chinese Society for Anesthesiology
esmo 2016
© European Society for Medical Oncology
Copy link
CopyCopied
Powered by Social Snap
MediPaper Medical Communications Agency Hong Kong Blog